Full Method Validation under ICH M10
Bioanalytical method validation establishes documented evidence that a method is suitable for its intended purpose and is mandatory for methods supporting regulatory submissions, including new drug applications, abbreviated new drug applications, and investigational new drug applications. Full validation, encompassing all validation parameters, is required for a new method or a new analyte, whereas partial validation may be appropriate for minor modifications to an already validated method, and cross-validation is required whenever study samples are analysed across two different laboratories or by two different analytical methods.
Bioanalytical method validation is the process of demonstrating and documenting that a bioanalytical method is accurate, precise, selective, sensitive, reproducible, and reliable for its intended purpose. It ensures that the analytical method consistently produces high-quality data throughout drug development and regulatory studies.
Bioanalytical method validation is performed to:
- Ensure accurate and reliable analytical results.
- Demonstrate that the method is suitable for its intended use.
- Meet regulatory requirements.
- Support pharmacokinetic (PK), bioavailability (BA), and bioequivalence (BE) studies.
- Ensure patient safety and product quality.
1. Full Validation
Full validation is performed when a new bioanalytical method is developed or when major changes are made to an existing method.
When is it Required?
- Development of a new analytical method.
- Change in analytical technique or instrumentation.
- Change in biological matrix.
- Major modification of the analytical procedure.
2. Partial Validation
Partial validation is carried out when minor modifications are made to an already validated method.
Examples
- Change in analyst.
- Change in laboratory.
- Small change in sample preparation.
- Minor modification in chromatographic conditions.
Only the affected validation parameters are re-evaluated.
3. Cross Validation
Cross validation compares the performance of two analytical methods or two laboratories to ensure comparable results.
When is it Required?
- Multi-center clinical studies.
- Method transfer between laboratories.
- Comparison of different analytical methods.
According to regulatory agencies (US FDA, EMA, ICH M10), a validated method should be:
- Accurate
- Precise
- Selective
- Sensitive
- Reliable
- Fully documented and traceable
Selectivity is established by analysing blank matrix from at least six individual donors to confirm the absence of interference at the retention time of the analyte and internal standard, thereby demonstrating that the method can distinguish the analyte from endogenous matrix components. The lower limit of quantification represents the lowest concentration that can be measured with acceptable accuracy and precision and, unlike the limit of detection, must simultaneously satisfy both accuracy and precision acceptance criteria. Accuracy, expressed as percentage of nominal concentration, and precision, expressed as percentage coefficient of variation, are evaluated both within a single analytical run and across multiple runs performed on different days, with regulatory acceptance criteria generally requiring accuracy within eighty-five to one hundred fifteen percent of nominal and precision not exceeding fifteen percent, with somewhat relaxed criteria of twenty percent permitted at the lower limit of quantification.
Definition
Selectivity is the ability of an analytical method to measure the analyte accurately in the presence of endogenous matrix components, metabolites, degradation products, or other interfering substances.
Acceptance Criteria
- No significant interference at the retention time of the analyte and internal standard.
Definition
Sensitivity is the ability of the method to detect and accurately quantify very low concentrations of the analyte. The Lower Limit of Quantification (LLOQ) is the lowest concentration that can be measured with acceptable accuracy and precision.
Acceptance Criteria (LLOQ)
- Accuracy: 80–120% of the nominal concentration.
- Precision (%CV): ≤ 20%.
Definition
Accuracy is the closeness of the measured value to the true or nominal value.
Acceptance Criteria
- LLOQ: 80–120%
- Low, Medium, High QC: 85–115%
Definition
Precision is the degree of agreement among repeated measurements under the same conditions.
Types
Intra-run Precision (Repeatability)
- Within the same analytical run.
Inter-run Precision (Intermediate Precision)
- Between different analytical runs or different days.
Acceptance Criteria
- LLOQ: ≤20% CV
- QC Samples: ≤15% CV
Matrix effect refers to alteration of analyte ionisation efficiency caused by co-eluting endogenous components and is assessed through post-column infusion experiments and calculation of the internal standard-normalised matrix factor, which corrects for analyte-specific ion suppression or enhancement using the behaviour of the stable isotope-labelled internal standard. Extraction recovery quantifies the efficiency of the sample preparation procedure by comparing analyte response in extracted matrix against that in a post-extraction spiked equivalent. Comprehensive stability assessment is required across multiple conditions, including short-term bench-top stability, freeze-thaw stability across repeated cycles, long-term frozen storage stability, processed sample stability within the autosampler, and stock and working solution stability, each evaluated against acceptance criteria requiring accuracy within eighty-five to one hundred fifteen percent of freshly prepared reference values. Dilution integrity confirms that samples exceeding the upper limit of quantification can be reliably diluted into the validated range, while carryover assessment confirms the absence of analyte transfer between sequential injections that could compromise the accuracy of subsequently analysed low-concentration samples.
Definition
The matrix effect occurs when components of the biological sample increase or decrease the ionization of the analyte during LC-MS/MS analysis.
Purpose
- Evaluate ion suppression or ion enhancement.
- Ensure accurate quantification.
Definition
Recovery is the efficiency of extracting the analyte from the biological matrix during sample preparation.
Purpose
- Assess extraction efficiency.
- Ensure consistent analyte recovery.
Definition
Stability studies determine whether the analyte remains unchanged during sample collection, storage, processing, and analysis.
Types of Stability
- Bench-top stability
- Freeze–thaw stability
- Long-term stability
- Processed sample (autosampler) stability
- Stock solution stability
Acceptance Criteria
- Measured concentration should be 85–115% of the nominal concentration.
Definition
Dilution integrity demonstrates that samples with concentrations above the calibration range can be diluted and still produce accurate and precise results.
Acceptance Criteria
- Accuracy: 85–115%
- Precision (%CV): ≤15%
Key Takeaway
Bioanalytical method validation establishes documented evidence that an analytical method is suitable for its intended purpose. By evaluating parameters such as selectivity, sensitivity, accuracy, precision, recovery, stability, matrix effect, dilution integrity, and carryover, validation ensures the generation of reliable, reproducible, and regulatory-compliant data for pharmaceutical research and clinical studies.
The complete set of bioanalytical validation parameters and their acceptance criteria are formally codified in International Council for Harmonisation guideline M10 on bioanalytical method validation, which harmonises the previously distinct expectations of the United States Food and Drug Administration and the European Medicines Agency into a single globally applicable standard.